CEACAM5 and neoplasm: Albalawi et al. showed that the treatment of EST-suffering mice with RJ at the doses of 200 and 400 mg/kg causes a significant reduction in the tumor volume and inhibition rate, body weight, tumor markers such as the serum level of alpha-fetoprotein (AFP), and carcinoembryonic antigen tumors (CAE).